Bioxcel therapeutics to present at the 40th annual j.p. morgan healthcare conference

New haven, conn., jan. 04, 2022 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that vimal mehta, ph.d., ceo of bioxcel therapeutics, will present corporate updates and plans for 2022 at the 40th annual j.p. morgan healthcare conference, being held virtually, on thursday, january 13, 2022 at 9:45 a.m. et.
BTAI Ratings Summary
BTAI Quant Ranking